个人简历

教育及工作经历
2017年11月—至今，副研究员，中国科学院宁波工业技术研究院慈溪生物医学工程研究所；
2014年1月—2017年11月，博士后，南京大学生命科学学院药学专业；
2014年2月—2015年4月，博士后，韩国国立蔚山科学技术大学；
2008年9月—2013年6月，博士，南京大学生命科学学院生物学；
2004年9月—2008年6月，本科，中国药科大学药学院药剂学。

研究领域

新型智能响应性水凝胶的合成与应用，以水凝胶为载体的催化研究""

近期论文

(1) Yang Zhou, Yu-Shun Yang, Xiao-Da Song, Liang Lu, Hai-Liang Zhu. Study of Schiff-Base-Derived with Dioxygenated Rings and Nitrogen heterocycle as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. Chem. Pharm. Bull. 2017, 65, 178-185;
(2) Yang Zhou, Yin Luo, Yu-Shun Yang, Liang Lu, Hai-Liang Zhu. Study of acylhydrazone derivatives with dioxygenated seven-membered ring as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. Med. Chem. Commun. 2016, 7, 1980-1987.
(3) Yang Zhou, Qingjie Liu, Weifeng Lv, Qingyu Pang, Rong Ben, Yong Qian, and Jing Zhao. Indazolin-s-ylidene–N-Heterocyclic Carbene Complexes of Rhodium, Palladium, and Gold: Synthesis, Characterization, and Catalytic Hydration of Alkynes. Organometallics 2013,13,3757-3759;
(4) Yang Zhou, Qian-Ru Du, Jian Sun, Jing-Ran Li, Fei Fang, Dong-Dong Li, Yong Qian, Hai-Bin Gong, Jing Zhao, and Hai-Liang Zhu. Novel Schiff-Base-Derived FabH Inhibitors with Dioxygenated Rings as Antibiotic Agents. ChemMedChem 2013, 8, 433 – 441;
(5) Yang Zhou, Jing Zhao, and Lei Liu. Meta-Selective Transition Metal Catalyzed Arene C-H Bond Functionalization. Angew.Chem. Int. Ed. 2009, 48, 7126-7128;
(6) Yin Luo†, Yang Zhou†, Jie Fu, Hai-Liang Zhu. 4,5-Dihydropyrazole derivatives containing oxygen-bearing heterocycles as potential telomerase inhibitors with anticancer activity. RSC Adv. 2014, 4, 23904.
(7) Dongqi Wang, Sheng Cai, Rong Ben, Yang Zhou, Xingwei Li, Jing Zhao, Wei Wei, Yong Qian. Direct Access to Isoindolinone Derivatives by Palladium-Catalyzed C–H Activation and Isocyanide Insertion by Using Molecular Oxygen as the Sole Oxidant. Synthesis 2014, 46, 2045-2050;
(8) Peng-Cheng Lv , Huan-Qiu Li , Juan Sun, Yang Zhou, Hai-Liang Zhu. Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents. Bioorg. Med. Chem. 2010, 18, 4606–4614;
(9) Kui Cheng, Qing-Zhong Zheng, Jin Hou, Yang Zhou, Chang-Hong Liu, Jing Zhao, Hai-Liang Zhu. Synthesis, molecular modeling and biological evaluation of PSB as targeted antibiotics. Bioorg. Med. Chem. 2010, 18, 2447–2455;
(10) Ying Yang, Lei Shi, Yang Zhou, Huan-Qiu Li, Zhen-Wei Zhu, Hai-Liang Zhu. Design, synthesis and biological evaluation of quinoline amide derivatives as novel VEGFR-2 inhibitors. Bioorg. Med. Chem. Lett. 2010, 20 6653-6656;
(11) Yin Luo, Huan-Qiu Li, Yang Zhou, Zi-Lin Li, Tao Yan, and Hai-Liang Zhu. Metronidazole–Deoxybenzoin Derivatives as Anti-Helicobacter pylori Agents with Potent Inhibitory Activity against HPE-Induced Interleukin-8. ChemMedChem 2010, 5, 1110 – 1116;
(12) Qingfu Zeng, Jie Fu, Yang Zhou, Yintao Shi, Hailiang Zhu. Photooxidation Degradation of Reactive Brilliant Red K-2BP in Aqueous Solution by Ultraviolet Radiation/Sodium Hypochlorite. Clean-Soil Air Water 2009, 37, 574–580;
(13) Zhong-Cheng Song,Gao-Yuan Ma, Yang Zhou, Qing-Shan Li ,Hai-Liang Zhu. Synthesis, Structure And Structure-Activity Relationship Analysis of 3-Tert-Butoxycarbonyl-2-Arylthiazolidine-4-Carboxylic Acid Derivatives as Potential Antibacterial Agents. AAPS 2009, 93-94.